Ridgeback Capital Investor
Ridgeback Capital is a private investment company that is focused on investing in life science companies.
Technology:
Cell_Therapies
Industry:
Investor
Headquarters:
New York, New York, United States
Zip:
NA
Founded Date:
2006-01-01
Employees Number:
11-50
Funding Status:
N/A
Investor Type:
Family Investment Office, Private Equity Firm, Venture Capital
Investment Stage:
Convertible Note, Early Stage Venture, Late Stage Venture, Post-Ipo, Secondary Market, Seed
Number Of Exits:
16
Acquisitions Number:
15
Investors Number:
28
Estimated Revenue:
$1M to $10M
Register and Claim Ownership